MARS Bioimaging Ltd

📍 Christchurch, New Zealand🗓 Founded 2007👥 23 employees💰 Last funded Feb 2022
Research Services🌐 marsbioimaging.com
Website LinkedIn
Mars Bioimaging Ltd (MBI) was formed in 2007 to commercialise the ground-breaking the MARS imaging system for its applications in medical diagnosis. The MARS imaging system is based on the new generation Medipix chip licensed out of CERN, Switzerland and technology developed by the University of Canterbury (UC) and partners. It has established itself as the world’s leading spectral (multi-energy ‘true colour’) imaging technology. It is the first commercially available spectral, high definition computed tomography (CT) system and has already demonstrated exciting applications.
2
Total investors
0
Early stage
0
Mid stage
1
Late stage
2007
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
New Zealand
2
Frequently asked questions
Who invested in MARS Bioimaging Ltd?
MARS Bioimaging Ltd has 2 investors on record on gritt.io and 1 late-stage investors.
When did MARS Bioimaging Ltd last raise funding?
The most recent investment in MARS Bioimaging Ltd recorded on gritt.io was in February 2022.
When was MARS Bioimaging Ltd founded?
MARS Bioimaging Ltd was founded in 2007.
What industry is MARS Bioimaging Ltd in?
MARS Bioimaging Ltd operates in Research Services. Find similar Research Services investors on gritt.io.
Where is MARS Bioimaging Ltd based?
MARS Bioimaging Ltd is headquartered in Christchurch, New Zealand.